What is BNTX's current stock price?

BNTX is currently trading at $90.46 with a daily change of +7.78%. Visit StocksRunner for live updates.

What are BNTX stock's key strengths?

BNTX current strengths include: Earnings are forecast to grow, Trading below its fair value, Upgraded on attractively valued. These are updated in real time by the StocksRunner IQ algorithm.

What are the risks associated with BNTX stock?

Current risk factors for BNTX include: Fair. Risk levels are assessed by StocksRunner based on volatility, sector strength, volume, and investor confidence.

What is BNTX's current StocksRunner IQ Score?

BNTX current StocksRunner IQ Score is: Sell. This score reflects aggregated earnings data, news sentiment, analyst ratings, and market momentum as of the latest update.

What factors influence BNTX's StocksRunner IQ Score?

BNTX StocksRunner IQ Score is a composite Credibility Score that weighs: quarterly earnings results vs. analyst expectations, breaking news sentiment and headline credibility, Wall Street analyst price target consensus, trading volume and price momentum, and sector-level risk indicators. All factors are aggregated in real time.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

BNTX Stock Analysis & IQ Rating | BioNTech

Q: Should I buy BNTX stock right now?

StocksRunner does not provide personalized investment advice. Our IQ Credibility Score for BNTX aggregates analyst sentiment, earnings performance, and news momentum to help you make an informed decision. The current IQ signal is: Sell. Always consider your own risk tolerance and consult a financial advisor before investing.

Q: What does a Strong Buy rating mean for BNTX?

A Strong Buy rating on StocksRunner indicates that the aggregated IQ score — drawing from earnings beats, analyst upgrades, and positive news sentiment — reflects high confidence in BNTX near-term growth potential. It is the strongest signal in the StocksRunner IQ rating scale.

BNTX

BioNTech

$90.46

+$6.57 | +7.78%

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$123.98

MKT CAP

$23.27B

52W Low

$79.52

VOL

$2.86M

P/E Ratio

N/A

AVG VOL

$1.09M

RSI

34.33

TREND

Sideways

BNTX Stock IQ

Login to see BioNTech (BNTX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

BNTX Target Price

Login to display

Strengths

BNTX Rewards

Upgraded on attractively valued

BNTX Rewards

Earnings are forecast to grow

BNTX Rewards

Trading below its fair value

Technical Indicators

BNTX Technical Indicators

Oversold

BNTX Price Performance

$109.38 (-17.30%)

$94.81 (-4.59%)

$104.34 (-13.30%)

$95.9 (-5.67%)

1year

6month

3month

1month

BNTX Analysts Opinion

Overall standing based on market and analyst consensus. menu Hover over the category for more information

BNTX Analysts opinion is negative and has getting worse from the past 3 months

BNTX Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

55%

Consensus Rating

0%

Buy
Opinion

22%

Trend
Score

100%

Potential
Score

BNTX Street Sentiment is bullish and have positive views on the near-term outlook

BNTX Risk Level

BNTX has Fair risk level

Risk Indicators

Beta greater than 1.0

Fair

LOW

HIGH

BNTX Performance Sentiment

Sentiments overview associated with events and the stock performance

55%

Positive

11 out of 20
events present

45%

Negative

9 out of 20
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Key Price Levels

Average key support and resistance price levels

Support Price

$83.89

Resistance Price

$110.89

Current Price Range

$83.89

$110.89

Show methods +

Analyst Consensus

Recent Upgrades and Downgrades

60%

Consensus Rating

BUY

3

Buy

2

Hold

0

Sell

Date

Action

Rating

Firm

Feb 19, 2026

Downgrade

a Market Perform

Leerink

Jan 30, 2026

Upgrade

Buy

Goldman Sachs

Jan 16, 2026

Upgrade

Buy

Goldman Sachs

Dec 11, 2025

Reiterate

Buy

Clear Street

Nov 10, 2025

Reiterate

Buy

HC Wainwright & Co.

Runners Also Watch

Close Price

Change

MRNA

Moderna

56.46

+2.63%

CRSP

CRISPR Therapeutics

51.13

-3.12%

BIIB

Biogen

190.45

+1.08%

BNTX Latest Analysis +

BioNTech Stock Tanks As Outlook Founder Exit Rattle s. BioNTech SE (NASDAQ:BNTX) was down sharply on Tuesday after issuing weaker‑than‑expected 2026 revenue guidance as Covid vaccine sales normalize and outlining a capital‑intensive pivot toward oncology.BNTX stock is sinking. See the chart and price action here.The company'.s co-founders Ugur Sahin and Ozlem Tureci plan to transition out by the end of 2026 to launch a new mRNA‑focused firm creating a combination that is pressuring near‑term

Tue Mar 10, 2026

$83.89 | -17.88%

Activity

Momentum

BioNTech Stock Falls 21% Over Turning To Loss In Q4 Weak FY26 Outlook Co-Founders Plan To Exit . (RTTNews) - Shares of BioNTech SE (BNTX) are moving down about 22 percent during Tuesday morning trading following the announcement of net loss in the fourth quarter and co-founders Ugur Sahin and Ö.zlem Tü.recis decision to establish an independent biotechnology company

Tue Mar 10, 2026

$83.89 | -17.88%

Momentum

BioNTech is Now Oversold (BNTX). Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which me

Tue Mar 10, 2026

$83.89 | -17.88%

Technical

BioNTech Tumbles as Founding Duo Plan to Leave to Start New Firm. BioNTech SEs founders will leave the company to start a new biotech focused on messenger RNA the technology behind their blockbuster Covid-19 vaccine dashing investors confidence in the firms prospects.

Tue Mar 10, 2026

$83.89 | -17.88%

Momentum

BioNTech Cofounders To Step Down. Stock Crumbles.. BioNTech stock crumbled Tuesday after the cofounders of the German biotech announced their plan to step down.The post BioNTech Cofounders To Step Down. Stock Crumbles. appeared first on Investor'.s Business Daily.

Tue Mar 10, 2026

$83.89 | -17.88%

Momentum

BioNTech falls on outlook departure of co-founders.

Tue Mar 10, 2026

$83.89 | -17.88%

Momentum

BioNTech Tumbles as Founding Duo Plan Leave to Start New Firm. BioNTech SEs founders will leave the company to start a new biotech focused on messenger RNA the technology behind their blockbuster Covid-19 vaccine dashing investors confidence in the firms prospects.

Tue Mar 10, 2026

$83.89 | -17.88%

Momentum

BioNTech Stock Tumbles As Co-Founders Pivot To New MRNA Venture. BioNTech SE (NASDAQ:BNTX) shares are down during Tuesday’.s premarket session as the company announced plans for its co-founders to transition into a new venture focused on next-generation mRNA innovations.With both companies focusing on their respective strategic priorities BioNTech expects to maximize value for patients and shareholders alike.Unexpected TransitionCo-founders Ugur Sahin and Özlem Türeci will move to lead thei

Tue Mar 10, 2026

$83.89 | -17.88%

Earnings

Momentum

Is BioNTech SE (BNTX) A Good Stock To Buy Now?. We came across a ish thesis on BioNTech SE on Memyselfandi007s Substack. In this article we will summarize the s thesis on BNTX. BioNTech SE’.s share was trading at $103.80 as of March 4th. BNTXs trailing and forward P/E were 166.87 and 7.04 respectively according to Yahoo Finance. BioNTech SE (BNTX) has transitioned from a COVID-19 vaccine pioneer [….]

Thu Mar 5, 2026

$101.95 | -1.78%

Potential

Moderna Faces Lawsuit From BioNTech Over Next-Generation COVID-19 Shot. ) has filed a patent infringement lawsuit against MRNA) alleging that Moderna'.s next-generation mNEXSPIKE relies on proprietary technology developed and patented by BioNTech.BioNTech widely recognized for its partnership with ) in delivering the first FDA-approved mRNA COVID-19 vaccine Comirnaty claims Moderna is using its patented streamlined vaccine design without authorization.Thomson Reuters published a of the law

Fri Feb 20, 2026

$110.15 | -0.25%

Activity

FAQ About BNTX Stock Insights

What is BNTX current stock price?

What are BNTX stock strengths?

What is BNTX Risk Level?

What is BNTX market cap and volume?

What is BNTX current Stock IQ?

Should I buy BNTX stock right now?

Is BNTX a Strong Buy right now?

What does a 'Strong Buy' rating mean for BNTX?

What does a 'Strong Sell' rating mean for BNTX?

What factors influence BNTX's Stock IQ?

Explore our BNTX Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored BNTX Stock Strategies
Effective Risk Management

FIND US ON

Receive our BNTX Daily Alerts

Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

BNTX

BioNTech

Set Alerts

Current Price

$90.46

+$6.57 | +7.78%

52W High

$123.98

MKT CAP

$23.27B

52W Low

$79.52

VOL

$2.86M

P/E Ratio

N/A

AVG VOL

$1.09M

RSI

34.33

TREND

Sideways

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Runners Also Watch

Symbol

Close

Change

MRNA

Moderna

56.46

+2.63%

CRSP

CRISPR Therapeutics

51.13

-3.12%

BIIB

Biogen

190.45

+1.08%

BNTX Price Performance

$109.38 (-17.30%)

$94.81 (-4.59%)

$104.34 (-13.30%)

$95.9 (-5.67%)

1year

6month

3month

1month

BNTX Analysts Opinion

Overall standing per market and analyst expectations. menu Hover over the category for more information

BNTX Analysts opinion is negative and has getting worse from the past 3 months

BNTX Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

55%

Consensus Rating

0%

Buy
Opinion

22%

Trend
Score

100%

Potential
Score

BNTX Street Sentiment is bullish and have positive views on the near-term outlook

BNTX Risk Level

BNTX has Fair risk level

Risk Indicators

Beta greater than 1.0

Fair

LOW

HIGH

BNTX Performance Sentiment

Sentiments overview associated with events and the stock performance.

55%

Positive

11 out of 20
events present

45%

Negative

9 out of 20
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Key Price Levels

Average key support and resistance price levels

Support Price

$83.89

Resistance Price

$110.89

Current Price Range

$83.89

$110.89

Show methods +

Latest Analyst Actions

Overall Wall Street Rating

60%

Consensus Rating

BUY

3

Buy

2

Hold

0

Sell

Date

Action

Rating

Firm

Feb 19, 2026

Downgrade

a Market Perform

Leerink

Jan 30, 2026

Upgrade

Buy

Goldman Sachs

Jan 16, 2026

Upgrade

Buy

Goldman Sachs

Dec 11, 2025

Reiterate

Buy

Clear Street

Nov 10, 2025

Reiterate

Buy

HC Wainwright & Co.

BNTX Stock IQ

Login to unlock BioNTech (BNTX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Target Price

Login to display

Stock Insights

Strengths

BNTX Rewards

Upgraded on attractively valued

BNTX Rewards

Earnings are forecast to grow

BNTX Rewards

Trading below its fair value

Technical Indicators

BNTX Technical Indicators

Oversold

BNTX Latest Analysis

BioNTech Stock Tanks As Outlook Founder Exit Rattle s. BioNTech SE (NASDAQ:BNTX) was down sharply on Tuesday after issuing weaker‑than‑expected 2026 revenue guidance as Covid vaccine sales normalize and outlining a capital‑intensive pivot toward oncology.BNTX stock is sinking. See the chart and price action here.The company'.s co-founders Ugur Sahin and Ozlem Tureci plan to transition out by the end of 2026 to launch a new mRNA‑focused firm creating a combination that is pressuring near‑term

Tue Mar 10, 2026

$83.89 | -17.88%

Activity

Momentum

BioNTech Stock Falls 21% Over Turning To Loss In Q4 Weak FY26 Outlook Co-Founders Plan To Exit . (RTTNews) - Shares of BioNTech SE (BNTX) are moving down about 22 percent during Tuesday morning trading following the announcement of net loss in the fourth quarter and co-founders Ugur Sahin and Ö.zlem Tü.recis decision to establish an independent biotechnology company

Tue Mar 10, 2026

$83.89 | -17.88%

Momentum

BioNTech is Now Oversold (BNTX). Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which me

Tue Mar 10, 2026

$83.89 | -17.88%

Technical

BioNTech Tumbles as Founding Duo Plan to Leave to Start New Firm. BioNTech SEs founders will leave the company to start a new biotech focused on messenger RNA the technology behind their blockbuster Covid-19 vaccine dashing investors confidence in the firms prospects.

Tue Mar 10, 2026

$83.89 | -17.88%

Momentum

BioNTech Cofounders To Step Down. Stock Crumbles.. BioNTech stock crumbled Tuesday after the cofounders of the German biotech announced their plan to step down.The post BioNTech Cofounders To Step Down. Stock Crumbles. appeared first on Investor'.s Business Daily.

Tue Mar 10, 2026

$83.89 | -17.88%

Momentum

BioNTech falls on outlook departure of co-founders.

Tue Mar 10, 2026

$83.89 | -17.88%

Momentum

BioNTech Tumbles as Founding Duo Plan Leave to Start New Firm. BioNTech SEs founders will leave the company to start a new biotech focused on messenger RNA the technology behind their blockbuster Covid-19 vaccine dashing investors confidence in the firms prospects.

Tue Mar 10, 2026

$83.89 | -17.88%

Momentum

Discover BNTX Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of BNTX. We're here to help you make informed investment decisions today.

FIND US ON

Receive our BNTX Daily Alerts

Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

BNTX Stock trends

BNTX Stock performance

BNTX Stock analysis

BNTX investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing BNTX

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing BNTX

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

BNTX Stock Analysis & IQ Rating | BioNTech

BNTX Stock IQ

BNTX Target Price

BNTX Analysts Opinion

BNTX Street Sentiment

BNTX Risk Level

BNTX Performance Sentiment

Key Price Levels

Analyst Consensus

Explore our BNTX Stock insights

Receive our BNTX Daily Alerts

BNTX Street Sentiment

BNTX Risk Level

Key Price Levels

Latest Analyst Actions

Discover BNTX Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of BNTX. We're here to help you make informed investment decisions today.

Receive our BNTX Daily Alerts

BNTX Alerts